Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-014998

Chairman and CEO bought 53,800 shares at $1.49 ($80,162)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2022-02-28 Purchase +53,800 $1.49 $80,162 11,303,506 D
Open-market purchases · 53,800 sh · avg $1.49 · $80,162
Loading xslF345X03/doc4.xml…